Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 42 results for "sun pharmaceutical industries"

Sun Pharma gains after settling patent litigation for generic

The announcement was made after market hours yesterday, 16 January 2018. Meanwhile, the S BSE Sensex was down 16.46 points, or 0.05% to 34,754.59. On the BSE, 66,000 shares were traded in the counter so far, compared with average daily volumes of 7.10 lakh ... Business Standard, 6 days ago
How desi brothers built a $1.8 bn drug co Rediff.com, 1 month ago

20 images for sun pharmaceutical industries

Business Standard, 3 weeks ago
Money Control, 1 week ago
Money Control, 1 week ago
Business Standard, 3 weeks ago
Money Control, 2 months ago
Money Control, 3 months ago
Business Standard, 1 week ago
Sify, 1 month ago
Business Standard, 1 month ago
Money Control, 4 months ago

Sun Pharma spurts on USFDA nod for new drug application

Sun Pharmaceutical Industries has announced that the US FDA has accepted a new drug application filed by its wholly owned subsidiary, for OTX 101 -cyclosporine A, ophthalmic solution - 0.09%, a novel nanomicellar formulation of cyclosporine A 0.09% in a ...
 Sify4 weeks ago Sun Pharma gains after USFDA accepts new drug application  Business Standard4 weeks ago BUZZ-India's Sun Pharma hits 5-month high after U.S. FDA accepts new drug application  Sify4 weeks ago BUZZ-India's Sun Pharmaceutical Industries falls on weak Q2 earnings  Sify2 months ago

Top buzzing midcap stocks to trade on January 8

Here are a few top buzzing midcap stocks picked by CNBC-TV18#39;s analysts in trade today -- Sun Pharmaceutical, Indoco Remedies, Goa Carbon, Sobha Developers, Shakti Pumps, Jaiprakash Associates, Jaypee Infratech, Venus Remedies, JSPL, and Globus Spirits.
 Money Control2 weeks ago
Business Standard

Sun Pharma recalls two batches of diabetic drug from US market

Sun Pharmaceutical Industries has started recalling two batches of Riomet (metformin hydrochloride) Oral Solution voluntarily from the US market due to microbial contamination.According to a notification put up by the US Food and Drug Administration in its ...
 Business Standard1 month ago Sun Pharma in focus after recall of product  Business Standard1 month ago Sun Pharma drops after recall of product  Business Standard1 month ago Sun Pharma slides on recall of diabetes drug  Sify1 month ago

Indian shares hit record highs for 3rd straight session

* NSE index up 0.06 pct, BSE index 0.23 pct higher * Pharma stocks gain for 4th session * Sun Pharmaceutical Industries hits 5-month high By Vishal Sridhar Dec 27 (Reuters) - Indian shares touched record highs for athird consecutive session on Wednesday, with ...
 Sify4 weeks ago Indian shares little changed after clocking record highs  Sify4 weeks ago Indian shares little changed in quiet start to new year  Sify3 weeks ago Indian shares flat ahead of derivatives expiry; metal stocks up  Sify3 weeks ago

Sun Pharma surges nearly 7% as eye drop gets FDA nod

FC Bureau City: New Delhi Shares of Sun Pharmaceutical Industries soared nearly 7 per cent on Wednesday after the US health regulator accepted a new drug application (NDA) for dry eye solution filed by the company's wholly owned subsidiary. Acceptance of NDA ...
 The Financial Chronicle3 weeks ago Sun Pharma shares surge 6.5%  Business Standard4 weeks ago Sun Pharma shares drop over 3% after Q2 earnings  Business Standard2 months ago

Reliance Communications leads gainers on BSE's 'A' group

India and Sun Pharmaceutical Industries are among the other gainers in the BSE's 'A' group today, 27 December 2017. Meanwhile, the S BSE Sensex was up 40.94 points, or 0.12% to 34,051.55. Reliance Communications surged 23.53% at Rs 26.35. The stock topped the ...
 Business Standard4 weeks ago
Business Standard

No major respite for Sun Pharma

The Sun Pharmaceutical stock, after seeing some gains post September quarter results, is now marginally below pre-result levels despite the recent positive news flow. So, what's keeping sentiment low in the counter?First the positive part. The latest ...
 Business Standard1 month ago Weekly wrap: Pharma stocks end Nov 13-17 week in red as Q2 results fail to spur investor interest  Money Control2 months ago

Sun Pharma drops after reporting weak Q2 results

after consolidated net profit skidded 59% to Rs 912 crore on 15% decline in sales to Rs 6590 crore in Q2 September 2017 over Q2 September 2016. The result was announced after market hours yesterday, 14 November 2017. The stock had dropped 1.19% to Rs 526.15 ...
 Business Standard2 months ago Sun Pharma may slide after weak Q2 outcome  Business Standard2 months ago
Money Control

Sun Pharmaceuticals Industries to discuss results

Sun Pharmaceuticals Industries will hold a meeting of the Board of Directors of the Company on 14 November 2017. Powered by Capital Market - Live News (This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) ...
 Business Standard2 months ago Sun Pharmaceutical Industries#39; board meeting on Tuesday, November 14, 2017  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less